title: Amiodarone: pearl or peril?
authors.forename: A
authors.initials: A
authors.lastname: Krahn
authors.forename: G
authors.initials: G
authors.lastname: Klein
authors.forename: A C
authors.initials: AC
authors.lastname: Skanes
authors.forename: R
authors.initials: R
authors.lastname: Yee
mesh_terms: D000638:Amiodarone / Q000191:economics / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000191:economics / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D011405:Propafenone / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D000638:Amiodarone